Short answer
CONMED Corp (CNMD) filed its Q1 2026 10-Q quarterly report on Apr 30, 2026 for the quarter ended Mar 31, 2026.
CONMED Corp Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $317.0M, down 1.3% YoY from $321.3M, driven by gastroenterology exits
- Operating margin 8.0% vs 5.0%; net margin 4.4% vs 1.9% YoY
- Orthopedic surgery best performer, sales $147.7M, up 6.8%; general surgery $169.3M, down 7.4%
- Operating cash flow $13.5M vs $41.5M; $37.0M stock repurchases and $7.0M asset-sale proceeds
- Inflation, supply-chain challenges, tariffs and potential refinancing needs; $61.8M planned 2026 repurchases
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other CONMED Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.